In the rapidly evolving landscape of nicotine use and public health policies, Ivan Kairatov stands out as a leading expert in biopharma, specializing in tech and innovation within the industry. His extensive experience in research and development offers valuable insights into the effects of
Healthcare in prison settings has become a focal point of concern, with an emphasis on the technological disconnect undermining patient safety and efficiency. This issue is underscored by findings from various health oversight bodies, indicating a critical lack of interoperability between prison
Pridopidine, an investigational therapy developed for Huntington's disease, recently faced a significant hurdle when the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended against its approval. This decision poses a challenge as it influences the European
Emerging as a groundbreaking innovation in biomedical sciences, Organ-on-Chips (OoC) technology has begun to transform traditional approaches to drug research and development. At the forefront of this revolution, these microengineered devices offer a physiological simulation of human organs,
Is the future of cancer therapy already taking shape in laboratories today? With each advance in medical science, there comes hope for more effective treatments against malignant diseases. Immunotherapy, a rapidly evolving approach, has been positioned as a groundbreaking method in combating cancer
As researchers intensify their quest to understand cancer progression, the spotlight has unexpectedly turned toward a surprising villain: senescent macrophages. These paradoxical cells, originally hailed as immune defenders, are now under scrutiny for their complicity in fueling tumor growth. The
